Christopher B. Ehrlich - Sep 26, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Stock symbol
EFTR
Transactions as of
Sep 26, 2022
Transactions value $
$10,377
Form type
4
Date filed
9/27/2022, 08:01 AM
Previous filing
Jun 13, 2022
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $10.4K +18.9K +117.92% $0.55 34.9K Sep 26, 2022 Direct
holding EFTR Common Stock 142K Sep 26, 2022 By Locust Walk Partners LLC F1
holding EFTR Common Stock 1.03K Sep 26, 2022 By Locust Walk Partners LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.